Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Teladoc Health

Teladoc Health (NYSE: TDOC) insider transactions

In the twelve months to 10 November 2026, executives and directors of Teladoc Health reported 38 open-market sales of 419,354 shares ($2.7m) and 1 open-market purchase of 10,000 shares ($69,400), by 7 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Teladoc Health shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
6 November 2026Nueno CarlosPresident, InternationalOpen-market sale, 10b5-1 plan−29,432$9.2035,312Form 4
2 October 2026Catapano Joseph RonaldChief Accounting OfficerOpen-market sale−655$5.6514,293Form 4
1 October 2026Catapano Joseph RonaldChief Accounting OfficerOption exercise+2,083—14,948Form 4
11 September 2026Divita Charles IiiChief Executive OfficerOpen-market sale−17,805$6.10465,535Form 4
10 September 2026Divita Charles IiiChief Executive OfficerOption exercise+3,642—444,180Form 4
10 September 2026Divita Charles IiiChief Executive OfficerOption exercise+39,160—483,340Form 4
3 September 2026Rodrigues Fernando M.President of BetterHelpOpen-market sale, 10b5-1 plan−9,812$6.510Form 4
2 September 2026Divita Charles IiiChief Executive OfficerOpen-market sale−18,327$6.30440,538Form 4
2 September 2026Vandervoort Adam CChief Legal Officer, SecretaryOpen-market sale−7,573$6.30117,616Form 4
2 September 2026Catapano Joseph RonaldChief Accounting OfficerOpen-market sale−274$6.3012,865Form 4
2 September 2026Bliss KellyPresident, U.S. Group HealthOpen-market sale−7,357$6.3092,832Form 4
2 September 2026Rodrigues Fernando M.President of BetterHelpOpen-market sale, 10b5-1 plan−5,439$6.309,812Form 4
2 September 2026Nueno CarlosPresident, InternationalOpen-market sale−6,200$6.3064,744Form 4
1 September 2026Divita Charles IiiChief Executive OfficerOption exercise+42,277—456,899Form 4
1 September 2026Divita Charles IiiChief Executive OfficerOption exercise+1,966—458,865Form 4
1 September 2026Vandervoort Adam CChief Legal Officer, SecretaryOption exercise+5,350—115,611Form 4
1 September 2026Vandervoort Adam CChief Legal Officer, SecretaryOption exercise+9,152—124,763Form 4
1 September 2026Vandervoort Adam CChief Legal Officer, SecretaryOption exercise+426—125,189Form 4
1 September 2026Catapano Joseph RonaldChief Accounting OfficerOption exercise+833—13,100Form 4
1 September 2026Catapano Joseph RonaldChief Accounting OfficerOption exercise+39—13,139Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Teladoc Health page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.